Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation
Adult growth hormone deficiency (AGHD) is a rare endocrine disorder characterized by an abnormal body composition, metabolic abnormalities associated with increased cardiovascular diseases, bone loss, and impaired quality of life. Daily subcutaneous injections with recombinant growth hormone (GH) ca...
Main Authors: | Martin Bidlingmaier, Beverly M.K. Biller, David Clemmons, Jens Otto L. Jørgensen, Hiroshi Nishioka, Yutaka Takahashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.1040046/full |
Similar Items
-
Corrigendum: Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation
by: Martin Bidlingmaier, et al.
Published: (2023-03-01) -
Once-Weekly Somapacitan as an Alternative Management of Growth Hormone Deficiency in Prepubertal Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trial
by: Ghina Tsurayya, et al.
Published: (2024-02-01) -
What do we do now that the long-acting growth hormone is here?
by: Bradley S. Miller
Published: (2022-08-01) -
Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan
by: Miller BS, et al.
Published: (2024-02-01) -
Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children
by: Hou L, et al.
Published: (2015-12-01)